Cara Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CARA and buy or sell other stocks, ETFs, and their options commission-free!

About CARA

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX. 

CEO
Imran Alibhai, PhD
CEOImran Alibhai, PhD
Employees
10
Employees10
Headquarters
Sugar Land, Texas
HeadquartersSugar Land, Texas
Founded
Founded
Employees
10
Employees10

CARA Key Statistics

Market cap
24.33M
Market cap24.33M
Price-Earnings ratio
-0.92
Price-Earnings ratio-0.92
Dividend yield
—
Dividend yield—
Average volume
36.27K
Average volume36.27K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$34.31
52 Week high$34.31
52 Week low
$8.13
52 Week low$8.13

People also own

Based on the portfolios of people who own CARA. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
Aurora Cannabis
Canopy Growth
Plug Power
Cronos Group
Corbus Pharmaceuticals
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.